Assignee
IMMUNETARGET INC
US·4 granted patents·1 pending application·4 citations·filing 2016–2021
Top patents by PatentIndex Score
5 records- 0181US11266648B2Substituted chromeno[2,3-d]pyrimidines as NF-κB inhibitorsIMMUNETARGET INC·Filed 2020·Granted Mar 8, 2022·1 cites·14 claims
- 0277US10660894B2Small molecule NF-κB inhibitorsIMMUNETARGET INC·Filed 2019·Granted May 26, 2020·1 cites·1 claims
- 0375US10226464B2Small molecule NF-κB inhibitorsIMMUNETARGET INC·Filed 2016·Granted Mar 12, 2019·2 cites·20 claims
- 0451US2022023301A1METHODS OF TREATING AUTOIMMUNE DISEASES WITH SMALL MOLECULE NF-kB INHIBITORSIMMUNETARGET INC·Filed 2021·Application pending·0 cites
- 0544US11083729B2Methods of treating cancer with small molecule NF-κB inhibitorsIMMUNETARGET INC·Filed 2018·Granted Aug 10, 2021·0 cites·17 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →